Bioserica to go public via a SPAC merger with A SPAC III Acquisition Corp in a $200m deal.

Bioserica, a British Virgin Islands business company specializing in the research, development, and manufacturing of bio-based antimicrobial materials, agreed to go public via a SPAC merger with A SPAC III Acquisition Corp, a special purpose acquisition company, in a $200m deal.